These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. Prognostic and Diagnostic Values of Novel Serum and Urine Biomarkers in Lupus Nephritis: A Systematic Review. Radin M; Miraglia P; Barinotti A; Fenoglio R; Roccatello D; Sciascia S Am J Nephrol; 2021; 52(7):559-571. PubMed ID: 34515043 [TBL] [Abstract][Full Text] [Related]
10. Longitudinal assessment of urinary ALCAM, HPX, and PRDX6 in Korean patients with systemic lupus erythematosus: implications for disease activity monitoring and treatment response. Kim JW; Baek WY; Jung JY; Kim HA; Lee SW; Suh CH Front Immunol; 2024; 15():1369385. PubMed ID: 38915417 [TBL] [Abstract][Full Text] [Related]
11. ALCAM and VCAM-1 as urine biomarkers of activity and long-term renal outcome in systemic lupus erythematosus. Parodis I; Gokaraju S; Zickert A; Vanarsa K; Zhang T; Habazi D; Botto J; Serdoura Alves C; Giannopoulos P; Larsson A; Svenungsson E; Gunnarsson I; Mohan C Rheumatology (Oxford); 2020 Sep; 59(9):2237-2249. PubMed ID: 31722419 [TBL] [Abstract][Full Text] [Related]
12. Current Insights on Biomarkers in Lupus Nephritis: A Systematic Review of the Literature. Palazzo L; Lindblom J; Mohan C; Parodis I J Clin Med; 2022 Sep; 11(19):. PubMed ID: 36233628 [TBL] [Abstract][Full Text] [Related]
13. Urine neutrophil gelatinase-associated lipocalin to predict renal response after induction therapy in active lupus nephritis. Satirapoj B; Kitiyakara C; Leelahavanichkul A; Avihingsanon Y; Supasyndh O BMC Nephrol; 2017 Aug; 18(1):263. PubMed ID: 28778196 [TBL] [Abstract][Full Text] [Related]
14. Soluble TNF-R1, VEGF and other cytokines as markers of disease activity in systemic lupus erythematosus and lupus nephritis. Adhya Z; El Anbari M; Anwar S; Mortimer A; Marr N; Karim MY Lupus; 2019 May; 28(6):713-721. PubMed ID: 31046570 [TBL] [Abstract][Full Text] [Related]
15. Urinary neutrophil gelatinase-associated lipocalin as a marker for disease activity in lupus nephritis. El Shahawy MS; Hemida MH; Abdel-Hafez HA; El-Baz TZ; Lotfy AM; Emran TM Scand J Clin Lab Invest; 2018 Jul; 78(4):264-268. PubMed ID: 29533691 [TBL] [Abstract][Full Text] [Related]
16. Serum and urine TNF-like weak inducer of apoptosis, monocyte chemoattractant protein-1 and neutrophil gelatinase-associated lipocalin as biomarkers of disease activity in patients with systemic lupus erythematosus. Mirioglu S; Cinar S; Yazici H; Ozluk Y; Kilicaslan I; Gul A; Ocal L; Inanc M; Artim-Esen B Lupus; 2020 Apr; 29(4):379-388. PubMed ID: 32041504 [TBL] [Abstract][Full Text] [Related]
17. Increased urinary levels of the leukocyte adhesion molecules ICAM-1 and VCAM-1 in human lupus nephritis with advanced renal histological changes: preliminary findings. Abd-Elkareem MI; Al Tamimy HM; Khamis OA; Abdellatif SS; Hussein MR Clin Exp Nephrol; 2010 Dec; 14(6):548-57. PubMed ID: 20714774 [TBL] [Abstract][Full Text] [Related]
18. A Review of Lupus Nephritis. Alforaih N; Whittall-Garcia L; Touma Z J Appl Lab Med; 2022 Oct; 7(6):1450-1467. PubMed ID: 35932197 [TBL] [Abstract][Full Text] [Related]
19. A panel of urinary proteins predicts active lupus nephritis and response to rituximab treatment. Davies JC; Carlsson E; Midgley A; Smith EMD; Bruce IN; Beresford MW; Hedrich CM; Rheumatology (Oxford); 2021 Aug; 60(8):3747-3759. PubMed ID: 33313921 [TBL] [Abstract][Full Text] [Related]
20. Proximity extension assay proteomics and renal single cell transcriptomics uncover novel urinary biomarkers for active lupus nephritis. Li Y; Tang C; Vanarsa K; Thai N; Castillo J; Lea GAB; Lee KH; Kim S; Pedroza C; Wu T; Saxena R; Mok CC; Mohan C J Autoimmun; 2024 Feb; 143():103165. PubMed ID: 38194790 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]